SEC Filings | Constellation Pharmaceuticals

SEC Filings

Filing date	Form	Description	Filing Group	View
Feb 20, 2019	3	Initial filing by director officer or owner of more than ten percent.	3,4,5	0000899243-19-004312.pdf 0000899243-19-004312.rtf View HTML
Feb 20, 2019	4	Statement of changes in beneficial ownership of securities	3,4,5	0000899243-19-004314.pdf 0000899243-19-004314.rtf View HTML
Feb 14, 2019	SC 13G/A	An amendment to the SC 13G filing	3,4,5	0000919574-19-001626.pdf 0000919574-19-001626.rtf 0000919574-19-001626.xls View HTML
Feb 14, 2019	SC 13G/A	An amendment to the SC 13G filing	3,4,5	0000929638-19-000276.pdf 0000929638-19-000276.rtf 0000929638-19-000276.xls View HTML
Feb 13, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	3,4,5	0000315066-19-000937.pdf 0000315066-19-000937.rtf View HTML
Feb 13, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	3,4,5	0001193125-19-037920.pdf 0001193125-19-037920.rtf 0001193125-19-037920.xls View HTML
Feb 13, 2019	SC 13G	A statement of beneficial ownership of common stock by certain persons	3,4,5	0001193125-19-038142.pdf 0001193125-19-038142.rtf 0001193125-19-038142.xls View HTML
Jan 07, 2019	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-19-003053.pdf 0001193125-19-003053.rtf 0001193125-19-003053.xls View HTML
Jan 03, 2019	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-19-001051.pdf 0001193125-19-001051.rtf 0001193125-19-001051.xls View HTML
Dec 17, 2018	8-K/A	Amendment to a previously filed 8-K	Current Reports	0001193125-18-351075.pdf 0001193125-18-351075.rtf 0001193125-18-351075.xls View HTML

Copyright Morningstar